Literature DB >> 22886910

The effect of whole body vibration therapy on bone density in patients with thalassemia: a pilot study.

Ellen B Fung1, Catherine A Gariepy, Aenor J Sawyer, Annie Higa, Elliott P Vichinsky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22886910      PMCID： PMC3845963          DOI： 10.1002/ajh.23305

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  29 in total

1.  High-frequency, low-intensity vibrations increase bone mass and muscle strength in upper limbs, improving autonomy in disabled children.

Authors:  M Loreto Reyes; Marta Hernández; Luz J Holmgren; Enrique Sanhueza; Raúl G Escobar
Journal:  J Bone Miner Res       Date:  2011-08       Impact factor: 6.741

2.  Changes in balance, functional performance and fall risk following whole body vibration training and vitamin D supplementation in institutionalized elderly women. A 6 month randomized controlled trial.

Authors:  An Bogaerts; Christophe Delecluse; Steven Boonen; Albrecht L Claessens; Koen Milisen; Sabine M P Verschueren
Journal:  Gait Posture       Date:  2011-01-20       Impact factor: 2.840

3.  Characterization of low bone mass in young patients with thalassemia by DXA, pQCT and markers of bone turnover.

Authors:  Ellen B Fung; Elliott P Vichinsky; Janet L Kwiatkowski; James Huang; Laura K Bachrach; Aenor J Sawyer; Babette S Zemel
Journal:  Bone       Date:  2011-04-05       Impact factor: 4.398

4.  The work and home activities questionnaire: energy expenditure estimates and association with percent body fat.

Authors:  Gladys Block; Christopher D Jensen; Torin J Block; Jean Norris; Tapashi B Dalvi; Ellen B Fung
Journal:  J Phys Act Health       Date:  2009

5.  Effect of high-frequency, low-magnitude vibration on bone and muscle in children with cerebral palsy.

Authors:  Tishya A L Wren; David C Lee; Reiko Hara; Susan A Rethlefsen; Robert M Kay; Frederick J Dorey; Vicente Gilsanz
Journal:  J Pediatr Orthop       Date:  2010 Oct-Nov       Impact factor: 2.324

Review 6.  Is bone formation induced by high-frequency mechanical signals modulated by muscle activity?

Authors:  S Judex; C T Rubin
Journal:  J Musculoskelet Neuronal Interact       Date:  2010-03       Impact factor: 2.041

7.  Treatment options for thalassemia patients with osteoporosis.

Authors:  Evangelos Terpos; Ersi Voskaridou
Journal:  Ann N Y Acad Sci       Date:  2010-08       Impact factor: 5.691

Review 8.  Bone turnover markers in the management of postmenopausal osteoporosis.

Authors:  Jacques P Brown; Caroline Albert; Bassam A Nassar; Jonathan D Adachi; David Cole; K Shawn Davison; Kent C Dooley; Andrew Don-Wauchope; Pierre Douville; David A Hanley; Sophie A Jamal; Robert Josse; Stephanie Kaiser; John Krahn; Richard Krause; Richard Kremer; Raymond Lepage; Elaine Letendre; Suzanne Morin; Daylily S Ooi; Alexandra Papaioaonnou; Louis-Georges Ste-Marie
Journal:  Clin Biochem       Date:  2009-04-10       Impact factor: 3.281

Review 9.  Mechanical signals as anabolic agents in bone.

Authors:  Engin Ozcivici; Yen Kim Luu; Ben Adler; Yi-Xian Qin; Janet Rubin; Stefan Judex; Clinton T Rubin
Journal:  Nat Rev Rheumatol       Date:  2010-01       Impact factor: 20.543

Review 10.  Interactions between osteoclasts, osteoblasts and immune cells: implications for the pathogenesis of bone loss in thalassemia.

Authors:  Evangelos Terpos; Ersi Voskaridou
Journal:  Pediatr Endocrinol Rev       Date:  2008-10
View more
  2 in total

1.  Cell Mechanosensitivity to Extremely Low-Magnitude Signals Is Enabled by a LINCed Nucleus.

Authors:  Gunes Uzer; William R Thompson; Buer Sen; Zhihui Xie; Sherwin S Yen; Sean Miller; Guniz Bas; Maya Styner; Clinton T Rubin; Stefan Judex; Keith Burridge; Janet Rubin
Journal:  Stem Cells       Date:  2015-06       Impact factor: 6.277

Review 2.  Does Whole-Body Vibration Treatment Make Children's Bones Stronger?

Authors:  Diana Swolin-Eide; Per Magnusson
Journal:  Curr Osteoporos Rep       Date:  2020-10       Impact factor: 5.096
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.